Biofrontera Inc. — Investor Relations & Filings
Filings indexed
350
across all filing types
Latest filing
2024-11-01
Major Shareholding Noti…
Country
US
United States of America
Listing
US
BFRI
Biofrontera Inc. is a biopharmaceutical company that commercializes a portfolio of pharmaceutical products for the treatment of dermatological conditions. The company specializes in photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used to treat actinic keratoses, a type of pre-cancerous skin lesion, and impetigo, a bacterial skin infection. Biofrontera focuses on establishing PDT as a standard of care in dermatology and utilizes a proprietary nanoemulsion technology to improve the stability and skin penetration of its formulations, potentially increasing clinical efficacy.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Major Shareholding Notification 2024 | 2024-11-01 | English | |
| Regulatory Filings 2024 | 2024-10-31 | English | |
| Major Shareholding Notification 2024 | 2024-10-23 | English | |
| Regulatory Filings 2024 | 2024-10-07 | English | |
| SCHEDULE 13G | 2024-09-12 | English | |
| Regulatory Filings 2024 | 2024-08-14 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13443155 | Major Shareholding Notification 2024 | 2024-11-01 | English | ||
| 13443156 | Regulatory Filings 2024 | 2024-10-31 | English | ||
| 13443157 | Major Shareholding Notification 2024 | 2024-10-23 | English | ||
| 13443158 | Regulatory Filings 2024 | 2024-10-07 | English | ||
| 13443159 | SCHEDULE 13G | 2024-09-12 | English | ||
| 13443160 | Regulatory Filings 2024 | 2024-08-14 | English | ||
| 13443161 | Interim / Quarterly Report 2024 | 2024-08-14 | English | ||
| 13443162 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443163 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443165 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443164 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443169 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443166 | Director's Dealing 2024 | 2024-07-17 | English | ||
| 13443167 | Regulatory Filings 2024 | 2024-06-24 | English | ||
| 13443168 | Regulatory Filings 2024 | 2024-06-14 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Biofrontera Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35198/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35198 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35198 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35198 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35198}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Biofrontera Inc. (id: 35198)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.